Concurrent Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Sell
11,647
-366
-3% -$76.1K 0.02% 614
2026
Q1
$2.54M Buy
12,013
+1,693
+16% +$365K 0.03% 539
2025
Q4
$2.12M Buy
10,320
+1,975
+24% +$372K 0.02% 554
2025
Q3
$1.31M Sell
8,345
-545
-6% -$84.2K 0.02% 581
2025
Q2
$1.49M Buy
8,890
+483
+6% +$71.7K 0.03% 501
2025
Q1
$1.16M Sell
8,407
-372
-4% -$47.4K 0.03% 499
2024
Q4
$1.04M Sell
8,779
-1,696
-16% -$198K 0.03% 475
2024
Q3
$1.16M Sell
10,475
-398
-4% -$41.6K 0.03% 428
2024
Q2
$1.07M Buy
10,873
+5,353
+97% +$545K 0.04% 413
2024
Q1
$618K Sell
5,520
-1,359
-20% -$147K 0.02% 488
2023
Q4
$693K Buy
+6,879
New +$683K 0.03% 412

Other funds holding CAH

Concurrent Investment Advisors's CAH Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Cardinal Health (CAH) stake by 3% in Q2 2026, selling an estimated $76.1K and leaving 11,647 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #614.

Concurrent Investment Advisors first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 417 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Concurrent Investment Advisors held 11,647 shares of Cardinal Health worth $2.77M as of Q2 2026.
  • Concurrent Investment Advisors sold 366 Cardinal Health shares in Q2 2026, an estimated $76.1K.
  • Cardinal Health made up 0.02% of Concurrent Investment Advisors's portfolio in Q2 2026, its #614 holding.
  • Concurrent Investment Advisors first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 417 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.